DAWN
Day One Biopharmaceuticals Inc
NASDAQ: DAWN · HEALTHCARE · BIOTECHNOLOGY
$21.53
+0.00% today
Updated 2026-04-23
Market cap
$2.22B
P/E ratio
—
P/S ratio
14.06x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$6 – $22
Volume
4.5M
Day One Biopharmaceuticals Inc (DAWN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-67.80%
Operating margin
-51.10%
ROE
-22.70%
ROA
-14.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-12.63M | — | — | — |
| 2020 | $0.00 | $-40.51M | — | — | — |
| 2021 | $0.00 | $-70.44M | — | — | — |
| 2022 | $0.00 | $-132.18M | — | — | — |
| 2023 | $0.00 | $-188.92M | — | — | — |
| 2024 | $131.16M | $-95.50M | 95.98% | -165.65% | -72.81% |
| 2025 | $158.18M | $-107.32M | 89.12% | -80.76% | -67.85% |